| Date Filed | Type | Description |
| 08/11/2023 |
4
| Hrustanovic Gorjan (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
| 08/19/2022 |
4
| Hrustanovic Gorjan (Director) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.44, valued at
$48.8k
|
|
| 06/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/19/2020 |
4
| Hrustanovic Gorjan (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 21,520 options to buy
@ $19, valued at
$408.9k
|
|
| 11/18/2020 |
3
| Hrustanovic Gorjan (Director) has filed a Form 3 on Olema Pharmaceuticals, Inc. |
| 08/21/2020 |
4
| Hrustanovic Gorjan (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 40,127 options to buy
@ $20, valued at
$802.5k
|
|
| 08/20/2020 |
3
| Hrustanovic Gorjan (Director) has filed a Form 3 on Kymera Therapeutics, Inc. |